Education and Knowledge in Pharmacogenomics: Still a Challenge?

Area of Science:

• Pharmacogenomics
• Clinical Practice Integration
• Healthcare Education

Background:

• Pharmacogenomics offers personalized medicine but faces significant adoption barriers in clinical settings.
• Healthcare professionals express limited understanding of pharmacogenomics and its practical application.
• Existing educational frameworks in professional schools and postgraduate programs inadequately cover pharmacogenomics.

Purpose of the Study:

• To identify and elucidate the key barriers hindering the widespread adoption of pharmacogenomics in routine patient care.
• To highlight the knowledge gaps among physicians, pharmacists, and nurses regarding pharmacogenomics.
• To examine the impact of educational deficits on pharmacogenomics implementation.

Main Methods:

• A qualitative review of existing literature and professional surveys was conducted.
• Barriers were identified through analysis of reported challenges faced by healthcare providers.
• Factors contributing to limited understanding and adoption were systematically documented.

Main Results:

• Limited professional knowledge and insufficient training curricula are primary obstacles to pharmacogenomics integration.
• Complex terminology, scarce clinical guidelines, and evolving evidence further impede understanding.
• Lack of awareness regarding test availability and clinical utility also contributes to slow adoption.

Conclusions:

• Addressing the knowledge and education gaps is crucial for successful pharmacogenomics implementation.
• Standardizing terminology, developing clear guidelines, and enhancing awareness are essential next steps.
• Enhanced pharmacogenomics education is vital for realizing its potential in patient care.